Procter & Gamble (PG) Cash & Equivalents (2009 - 2026)

Procter & Gamble (PG) has 18 years of Cash & Equivalents data on file, last reported at $12.3 billion in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $12.3 billion, up 34.99% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.3 billion (up 34.99% YoY), and the FY2025 annual result was $9.6 billion, up 0.78% from the prior year.
• Cash & Equivalents grew to $12.3 billion in Q1 2026 per PG's latest filing, from $10.8 billion in the prior quarter.
• Over five years, Cash & Equivalents peaked at $12.3 billion in Q1 2026 and troughed at $6.7 billion in Q3 2022.
• A 5-year average of $9.1 billion and a median of $9.1 billion in 2025 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2022 and 2023: Cash & Equivalents plunged 40.63% in 2022, then jumped 45.05% in 2023.
• A 5-year view of Cash & Equivalents shows it stood at $6.9 billion in 2022, then increased by 15.12% to $7.9 billion in 2023, then advanced by 29.66% to $10.2 billion in 2024, then climbed by 5.82% to $10.8 billion in 2025, then rose by 13.68% to $12.3 billion in 2026.
• Business Quant data shows PG's Cash & Equivalents at $12.3 billion in Q1 2026, $10.8 billion in Q4 2025, and $11.2 billion in Q3 2025.